Results 91 to 100 of about 156,014 (309)
Aims Golcadomide is a potential first‐in‐class oral CELMoD™ agent for the treatment of lymphoma. This study aims to develop model‐informed drug development (MIDD) approaches to support optimal dose selection of golcadomide in combination with immunotherapy rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R‐CHOP) in alignment with ...
Xirong Zheng +7 more
wiley +1 more source
Risperidone-induced reversible neutropenia
Vasanth Kattalai Kailasam,1 Victoria Chima,2,* Uchechukwu Nnamdi,3,* Kavita Sharma,4,* Kairav Shah5 1College of Medicine, University of Illinois, Chicago, IL, USA; 2Mount Sinai Beth Israel Medical Center, New York, NY, USA; 3Albert Einstein College of ...
Kattalai Kailasam V +4 more
core
Review on Congenital neutropenia, with data on clinics, and the genes ...
Hess, JL, JL Hess
core +1 more source
Cefepime exposure in prolonged or intermittent infusion in critically ill children
Aims Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient.
Marc Hobeika +12 more
wiley +1 more source
Occurrence of febrile neutropenia and neutropenia grade on day 8.
Occurrence of febrile neutropenia and neutropenia grade on day 8.
Yoshihiko Furuya (6612659)
core +1 more source
Aims This study aimed to improve the understanding of lithium's safety profile by analysing the frequency and distribution of reported adverse drug reactions (ADRs) compared to second‐generation antipsychotics (SGAs). Methods Individual case safety reports from VigiBase (1968–October 2023) involving individuals older than 2 years, with lithium or SGAs ...
Lisa T. Ringeling +8 more
wiley +1 more source
Neonatal neutropenia is a common laboratory finding noted on the complete blood cell count of neonates in the intensive care unit. Neonatal neutropenia has various causes, ranging from maternal conditions to congenital syndromes to immune-mediated ...
Scott Moerdler, M. Susan LaTuga
core +1 more source
This review systematically summarizes the major molecular mechanisms governing TAM polarization and their coordinated interactions. It further highlights recent advances in nanoagonist‐based strategies that intervene in these pathways to reprogram TAMs, critically discussing their therapeutic potential, current limitations, and translational prospects.
Siqi Fang +7 more
wiley +1 more source

